Psychiatric factors are etiologically important in a proportion of patients with erectile dysfunction. We determined the prevalence of psychopathology and the impact it has on current erectile dysfunction (ED) assessment and management.
Introduction
The prevalence of psychiatric pathology in the general population has been estimated to range between 25 ± 40%. 1, 2 The true prevalence of erectile dysfunction in men is largely unknown. However, studies such as the Massachusetts Male Aging Study, have estimated that ED is present in 10 ± 50% 3 of men depending on the age of the population. It is not surprising, therefore, that a proportion of patients presenting to the urologist with a main complaint of ED will have signi®cant psychopathology since psychopathology and erectile disturbances are both common.
Many studies have been geared to the assessment of psychosocial stressors in the ED population. 4, 5 It is accepted that psychological distress can have a grave detrimental effect on sexual function. 6 Entities such as`performance anxiety' and relationship discord are recognized as etiologic factors for ED. However, there is limited information on the clinical importance of the coexistence of psychiatric problems in men with erectile dif®culties.
The purpose of this study was to determine (1) the prevalence of psychiatric disease in a population referred initially to a urology clinic for ED, (2) the ability of urologists to detect psychiatric conditions and (3) the effects that (1) and (2) had on the overall assessment and treatment choices.
Methods
A group of 120 consecutive men presenting for the ®rst time to the Human Sexuality Clinic in a threemonth period were prospectively investigated. Each patient participated in a structured interview conducted by the urologists and which included history and physical examination. Blood was drawn for a hormonal assessment, at initial presentation, between 9 and 11 am. Patients were also re-interviewed by a nurse specialist in ED and diagnostic intracavernosal injection (DICI) with vaso-active drugs was performed.
In a second visit, the patient and his partner were then seen by the Human Sexuality Group's team psychiatrist. The patient went through a full interview and mental status examination. The interview structure is shown in Table 1 . The patient was assessed for psychological stressors and psychiatric disease. All psychiatric diagnoses were made according to criteria in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV TM ). 7 Patients were seen in follow-up for review of ®ndings. All subsequent appointments were documented and treatment choices were recorded. The demographics of patients with psychiatric disease (PD group) and those without (NPD group) were compared. These factors included: age, smoking history, diabetic history, cardiac and psychiatric medications, serum testosterone, results of DICI, and response to oral medications. These included either yohimbine or trazodone since the study was conducted prior to the availability of sildena®l.
The Mann ± Whitney U test was utilized to determine statistical signi®cance. Treatment choice differences between the two groups were also analyzed. A subanalysis was performed in the PD group. Patients with psychopathology were separated into those with multiple organic risk factors (ie diabetes, coronary artery disease, smoking, etc.) and those without. Outcomes were assessed between these two subsets.
Results
The prevalence of signi®cant psychiatric disease in this population (PD group) was 40a120 (33%). The diagnoses included Major Depressions, Substance Dependence (alcohol andaor drugs), Schizophrenia, and Anxiety Disorder ( Table 2) . Of the 40 patients with psychiatric disease, the majority of patients had a diagnosis of depression or chemical dependence. An example of the criteria used for the diagnosis of major depression is shown in Table 3 . There were several patients with severe psychosocial stressors, such as relationship discord (2 patients ending their long-term relationships), egodystonic homosexuality, extramarital affairs (n 3), and ®nancialajob stress. These patients, however, did not have a psychiatric disease and were not included in the 40 patients with`true' psychiatric disorders.
Of the 40 patients in the PD (psychiatric diagnosis) group, only 16 (40%) were recognized and highlighted by the urologist in the original interview.
The demographics of PD group versus NPD group (patients with no psychiatric diagnosis, n 80) are shown in Table 4 . There was no statistically Psychiatric abnormalities in men with ED JC Lee et al signi®cant difference in any of the factors. Patients' age in both groups were similar as were their past diabetic and cardiac histories. As expected there was a greater percentage of patients in PD group who were on psychiatric medications; however, the difference did not reach statistically signi®cant levels.
In terms of investigations, namely serum testosterone, cavernosometry, and response to empiric administration of yohimbine andaor trazodone, again there was no signi®cant difference between the two groups ( Table 5 ).
The initial choice of treatment for patients in each group were tabulated (Table 6 ). Modalities included: oral pharmacotherapy, androgen supplementation, intracorporeal injection (ICI) of vaso-active drugs, the use of vacuum devices, and psychiatric treatment. Some patients refused treatment, choosing to return for follow-up only if they or their partners could reach agreement on the proposed therapeutic plan. A ®nal group of patients did not return to clinic for review of their results. They did not inform the urologist, the psychiatrist, or the nurse of their desire for no further intervention; these patients were considered`lost'.
In the psychiatric group (PD group), 22.5% of the patients needed, were offered and accepted psychiatric treatment as opposed to only 1.25% in NPD group; this difference was found to be statistically signi®cant. In the PD group, one patient received electroconvulsive therapy; three patients underwent behavioural therapy. Four of these nine patients experienced return of their erections after psychiatric treatment. Two patients were admitted to hospital for their depression, one patient after a suicide attempt.
There was a much larger proportion of patients in NPD group who refused treatment (42.5% vs 20%). This difference was statistically signi®cant. A larger percentage of the patients with psychopathology were none-compliant with follow-up; however, this was not found to be statistically signi®cant (P`0.32). No signi®cant difference existed in any of the other treatment modalities.
The PD group was then further analyzed. It was noted that ®ve patients (12.5%) had multiple vascular risk factors (diabetes, smoking, hypertension, previous myocardial infarctions) and yet had completely normal investigations, including response to intracorporeal injection of vaso-active agents. Of the nine patient with major psychopathology, who had abnormal DICI, ®ve (55.6%) had multiple organic risk factors. Three of nine (33%) had no vascular risk factors yet had abnormal DICI.
Discussion
The prevalence of psychopathology in the group of 120 patients was very similar to the estimated prevalence of psychiatric disease in the general population. The prevalence found in this study might be an underestimation. Many patients due to apathy secondary to the symptoms of their psychiatric disorder may not present to a physician with problems related to erectile dysfunction. There is still a large stigma associated with psychiatric disease as perceived by society and to ED as perceived by the patient. In addition, many patients have far greater issues that supercede their problems with sexual function. Erectile dysfunction is a quality of life issue whereas some psychiatric disorders are a serious health matter that may compromise life, as evidenced by the patients who attempted suicide or required hospitalization.
Of clinical consequence was the ®nding that only 33% of patients with signi®cant psychopathology were identi®ed in the structured and directed interview by the urologist. There may be several reasons for this. The urological interview tended to be focussed more on`medical' problems. The initial interview was also under time constraints. The average length of the appointment was estimated to be approximately thirty minutes, in which time a history, physical examination, and initial counseling and explanations had to be completed. The appointments with the nurse and with the psychiatrist were much more generous in terms of time, allotting sixty to ninety minutes for interviews. Since the urologist obtained the majority of the medical information, the nurse had more time to delve in questions in the psychosocial and psychiatric realm. Also of note, it was infrequent that patients presenting initially to the urologist were accompanied by their partners. However, they Psychiatric abnormalities in men with ED JC Lee et al were consistently and vigorously encouraged to bring their partners to any further interview and follow-up appointments. Only about half of the partners complied. This discouraging lack of interest by the partner and its consequences was reported previously by our group. 8 The apparent indifference of the partner is viewed as detrimental because on several occasions it was the partner who provided clues as to the presence of psychiatric concerns. Thus, the importance of a directed assessment including psychiatric evaluation is selfevident. As mentioned previously, there were many patients with multiple psychosocial stressors and there were a few patients suspected to have pure psychogenic impotence. However, it is important to distinguish these patients from those with true psychiatric disorders. Previous studies have already determined the importance of psychogenic causes. The focus of this study was primarily in determining the presence of psychiatric disease.
It is not surprising that there was no signi®cant difference in the demographics as psychiatric disease does not predispose nor does it protect against the development of cardiac, diabetic, or endocrine conditions. As expected, a large but equally distributed proportion of patients in each group included current smokers or ex-smokers. The clinical laboratory-based investigations (blood chemistries, hormonal screening and cavernosometry) showed similar results in both groups. Again, psychiatric disease per se do not predispose to abnormal cavernosometry or abnormal hormone pro®les. However, there is concern about the effects of psychiatric medications on erectile function and libido. Although a trend was seen in this study suggesting a negative effect on erectile function, the differences did not reach signi®cance. The limited sample in the study does not con®rm or refute the possibility of a detrimental activity of these medications.
The choice of treatment was remarkably similar in both groups. The anticipated exception was that more of the patients with psychiatric disorders underwent further psychiatric treatment. Surprisingly, those with an`organic' etiology were more likely not to pursue further treatment. However, it is relevant to emphasize here that the study was conducted prior to the availability of effective oral medication (eg sildena®l). It is likely that the proportion of those choosing`no treatment' would be much smaller in view of the new therapy. The majority of the outcomes were not signi®cantly different. As expected, more of the patients with psychiatric disorders underwent further psychiatric treatment. On the other hand, patients in the PD group were more likely to be non-compliant with follow-up. This may have been due to the underlying psychiatric factors such as depression and chemical dependence.
It is worth noting that in the PD group there were ®ve patients who had multiple vascular risk factors, and yet an excellent response to vaso-active drugs. This ®nding suggests that their psychiatric disease was the predominant etiological factor. More signi®cantly, there were nine patients who were treated by the psychiatrist with various modalities. It is evident that, if these men had not been identi®ed as harboring psychiatric conditions, their ED would have been treated differently. Four of these patients had successful return of their erections once their psychiatric disease was dealt with. Of course it is impossible to tell whether they would have been equally favorable with urological intervention alone. Nevertheless successful outcome in these patients needs to go beyond the ability to produce a rigid penis. Untreated psychiatric conditions would result in greater disharmony and the emergence of problems of greater relevance than those solely focused on the genitalia.
Conclusion
Psychiatric disease is prevalent in the general population, as well as in those patients presenting to the urologist with erectile dysfunction. It is important that the patient be evaluated and treated as a whole. It is very tempting when treating erectile dysfunction to direct all efforts solely on thè vascular organ' and to ignore supratentorial factors. This situation may become more common with contemporary pharmacotherapy. However, many patients do not comply with follow-up despite the availability of services and the clear advice about the need for psychiatric intervention. Properly trained and competent sexologists are in short supply and their approaches are expensive, long term, and only moderately effective. It is evident that, despite the best efforts by physicians, the much lamented`medicalization of sexuality' 9 is an unavoidable reality in most societies.`Phallodynamically challenged' men will continue to receive exclusively pharmacological treatment. This is primarily by their own choice in isolation or by the lack of affordable complementary therapies.
